PortfoliosLab logoPortfoliosLab logo
NEFRX vs. LCTIX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

NEFRX vs. LCTIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loomis Sayles Core Plus Bond Fund (NEFRX) and Leader Capital High Quality Income Fund Institutional Shares (LCTIX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NEFRX achieves a 0.31% return, which is significantly lower than LCTIX's 2.03% return. Over the past 10 years, NEFRX has underperformed LCTIX with an annualized return of 2.17%, while LCTIX has yielded a comparatively higher 5.28% annualized return.


NEFRX

1D
0.09%
1M
0.45%
YTD
0.31%
6M
0.08%
1Y
5.38%
3Y*
3.62%
5Y*
0.04%
10Y*
2.17%

LCTIX

1D
0.09%
1M
0.72%
YTD
2.03%
6M
2.43%
1Y
5.32%
3Y*
6.27%
5Y*
5.79%
10Y*
5.28%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NEFRX vs. LCTIX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NEFRX
Loomis Sayles Core Plus Bond Fund
0.31%7.24%0.60%5.91%-12.94%-1.68%10.29%8.76%-0.86%4.92%
LCTIX
Leader Capital High Quality Income Fund Institutional Shares
2.03%5.12%6.49%8.47%2.64%2.41%12.94%1.55%6.64%4.79%

Correlation

The correlation between NEFRX and LCTIX is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.36

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (10Y)
Calculated over the trailing 10-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Aug 2, 2010

0.21

The correlation between NEFRX and LCTIX shifts across timeframes, from 0.15 (10 years) to 0.36 (1 year), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NEFRX vs. LCTIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEFRX
NEFRX Risk / Return Rank: 3131
Overall Rank
NEFRX Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
NEFRX Sortino Ratio Rank: 3333
Sortino Ratio Rank
NEFRX Omega Ratio Rank: 2929
Omega Ratio Rank
NEFRX Calmar Ratio Rank: 3535
Calmar Ratio Rank
NEFRX Martin Ratio Rank: 2727
Martin Ratio Rank

LCTIX
LCTIX Risk / Return Rank: 9292
Overall Rank
LCTIX Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
LCTIX Sortino Ratio Rank: 9797
Sortino Ratio Rank
LCTIX Omega Ratio Rank: 9797
Omega Ratio Rank
LCTIX Calmar Ratio Rank: 9090
Calmar Ratio Rank
LCTIX Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEFRX vs. LCTIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loomis Sayles Core Plus Bond Fund (NEFRX) and Leader Capital High Quality Income Fund Institutional Shares (LCTIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NEFRXLCTIXDifference
Sharpe ratioReturn per unit of total volatility

-1.17

Sortino ratioReturn per unit of downside risk

-3.66

Omega ratioGain probability vs. loss probability

1.28

2.05

-0.77

Calmar ratioReturn relative to maximum drawdown

2.22

4.56

-2.34

Martin ratioReturn relative to average drawdown

6.44

19.47

-13.03

NEFRX vs. LCTIX - Sharpe Ratio Comparison

The current NEFRX Sharpe Ratio is 1.55, which is lower than the LCTIX Sharpe Ratio of 2.72. The chart below compares the historical Sharpe Ratios of NEFRX and LCTIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NEFRXLCTIXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.55

2.72

-1.17

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.01

2.39

-2.39

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.44

0.84

-0.40

Sharpe Ratio (All Time)

Calculated using the full available price history

0.74

0.77

-0.04

Drawdowns

NEFRX vs. LCTIX - Drawdown Comparison

The maximum NEFRX drawdown since its inception was -25.45%, roughly equal to the maximum LCTIX drawdown of -24.76%. Use the drawdown chart below to compare losses from any high point for NEFRX and LCTIX.


Loading charts...

Drawdown Indicators


NEFRXLCTIXDifference

Max Drawdown

Largest peak-to-trough decline

-25.45%

-24.76%

-0.69%

Max Drawdown (1Y)

Largest decline over 1 year

-2.92%

-1.17%

-1.75%

Max Drawdown (3Y)

Largest decline over 3 years

-7.95%

-1.29%

-6.66%

Max Drawdown (5Y)

Largest decline over 5 years

-18.55%

-3.70%

-14.85%

Max Drawdown (10Y)

Largest decline over 10 years

-18.76%

-23.61%

+4.85%

Current Drawdown

Current decline from peak

-1.89%

0.00%

-1.89%

Average Drawdown

Average peak-to-trough decline

-3.97%

-3.85%

-0.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.17%

0.27%

+0.90%

Volatility

NEFRX vs. LCTIX - Volatility Comparison

Loomis Sayles Core Plus Bond Fund (NEFRX) has a higher volatility of 1.36% compared to Leader Capital High Quality Income Fund Institutional Shares (LCTIX) at 0.62%. This indicates that NEFRX's price experiences larger fluctuations and is considered to be riskier than LCTIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NEFRXLCTIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

1.36%

0.62%

+0.74%

Volatility (6M)

Calculated over the trailing 6-month period

2.73%

1.45%

+1.28%

Volatility (1Y)

Calculated over the trailing 1-year period

4.19%

1.97%

+2.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

6.23%

2.44%

+3.79%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

5.04%

6.31%

-1.27%

NEFRX vs. LCTIX - Expense Ratio Comparison

NEFRX has a 0.71% expense ratio, which is lower than LCTIX's 1.08% expense ratio.


Dividends

NEFRX vs. LCTIX - Dividend Comparison

NEFRX's dividend yield for the trailing twelve months is around 3.61%, less than LCTIX's 5.64% yield.


PositionTTM20252024202320222021202020192018201720162015
LCTIX
Leader Capital High Quality Income Fund Institutional Shares
5.64%5.90%5.91%5.50%2.31%1.93%1.73%2.92%3.67%2.56%0.00%0.00%
NEFRX
Loomis Sayles Core Plus Bond Fund
3.61%3.97%3.90%3.58%3.10%2.34%4.04%2.51%2.87%2.68%3.17%2.58%

Frequently Asked Questions


NEFRX and LCTIX have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NEFRX has higher volatility (1.36%) compared to LCTIX (0.62%). In terms of maximum drawdown, NEFRX dropped -25.45% vs LCTIX's -24.76%.

LCTIX currently has the higher Sharpe Ratio (2.72 vs 1.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NEFRX and LCTIX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer